# Remidio
> Remidio is a pioneer in AI-driven eye care, leading the shift from care of the eye to healthcare through the eye.

Remidio designs and manufactures portable, easy-to-use eye screening devices integrated with artificial intelligence. The technology enables non-invasive screening for vision-threatening conditions such as diabetic retinopathy, glaucoma, and age-related macular degeneration (AMD) at the point of care.

## Core Products & Hardware
- [Handheld Fundus Camera - Remidio FOP NM10](https://www.remidio.com/fop): Non-mydriatic, smartphone-based portable fundus camera with offline AI to detect disease like Diabtetic retinopathy, Glaucoma, Age-Related Macular Degeneration.
- [Widefield Fundus Camera - Pristine 5.0](https://www.remidio.com/pristine-5-0): A next-generation widefield retinal camera that delivers compact, high-resolution, true-color retinal imaging for precise photo-documentation of peripheral lesions and retinal diseases.​
- [Portable Eye screening kit - InstaEyeClinic](https://www.remidio.com/instaeyeclinic-kit): Early Detection Of At-Risk Patients And Monitoring ​By Bringing Eye Testing Closer To The Patient​.
- [Pediatric Fundus Camera for ROP - Insta Neubo 130](https://www.remidio.com/insta-neubo-130): The world's first AI-enabled pediatric, small-pupil ultra-widefield retinal imaging system. Uniform peripheral illumination and enhanced screening precision built exclusively for ROP screening and pediatric retinal disorders.
- [Automated small pupil Fundus Camera - InstaZ](https://www.remidio.com/remidio-instaz): A next-generation automated retinal camera delivering high-resolution, true-colour imaging in small pupils, with on Edge AI.
- [Optical Biometer - Pristine OBM12](https://www.remidio.com/pristine-obm-12): One Scan. 12 Parameters. Built for the Myopia Clinic. Fast, integrated refraction and ocular biometry for confident, objective clinical decisions.

## AI Solutions & Software
- [Remidio MediosHI DR AI](https://www.remidio.com/medios-hi-dr-ai): On-the-edge AI analysis of retinal images. Screens for diabetic retinopathy in a single tap, delivering rapid point-of-care results, anytime, anywhere for detecting Diabetic Retinopathy, Glaucoma, and AMD directly on the device without requiring internet connectivity.
- [Remidio Connect](https://www.remidio.com/remidio-connect): A secure, cloud-based platform connecting retinal imaging devices, AI outputs, clinicians, and health systems. It centralises image management, review, reporting, and referrals for large-scale screening across distributed care settings.​

## Clinical Evidence & Company Information
- [Clinical Validation & Publications](https://www.remidio.com/remidio-mirror): Peer-reviewed research, clinical studies, and validation trials demonstrating device accuracy and AI performance.
- [About Remidio](https://www.remidio.com/about-us): Learn more about the mission to prevent avoidable blindness globally through affordable and accessible technology.
- [Contact](https://www.remidio.com/contact-us): Get in touch with the sales, marketing, or technical support teams.